Of course the earlier available evidence would have supported the benefits of CBT/GET.
When that is reported I quote my experience. I used to have very good, very experienced doctors who took a pragmatic view of the illness. Suddenly in about 1992/93 my then consultant told me that his clinic was to be closed. Patients were to be transferred to a new CFS clinic under the control of psychotherapists. He said I could go if I wanted to but he did not recommend it.
I presume that this was a nationwide initiative. In such circumstances it is hardly surprising that the available evidence, at the time of the preparation of NICE guidelines, would have shown the benefits of CBT/GET. One also has to consider what evidence might have been made available but wasn't. Is this not why you have to try to refute hypotheses rather than confirm them?
A quick bit of background information as to how NICE produces their treatment recommendations:
If we go back to the period 2005 - 2007, when the NICE guideline development group (GDG) were in action, they were working to the usual NICE remit - which is basically to consider all the results from clinical trials that have been published in peer reviewed journals
NICE don't pay much attention to research into causation - because they are producing a clinical guideline that concentrates on clinical assessment, diagnosis and management
One way in which a GDG assesses the 'Gold Standard' evidence from clinical trials is to commission a systematic review of the literature - which is what they did from the University of York. The York systematic review did a pretty exhaustive search of all the results from trials at the time (so I don't think anything was missed out) and rated the quality of all the trials that they looked at
It wasn't therefore surprising, in view of what had been published at the time, that NICE then concluded that the only two safe and effective treatment options for ME/CFS were CBT and GET
Unfortunately, patient evidence (from surveys etc) and clinician evidence (as to what experienced docs believe works and does not work) is given very low priority by NICE - even when this evidence conflicts with results from RCTs, as is the case with ME/CFS……….